Combining targeted therapeutics in the era of precision medicine

Por Papadatos-Pastos, D, De Miguel Luken, M J, Yap, Timothy A
Publicado no Br J Cancer (2015)

BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome

Por Saridaki, Z, Papadatos-Pastos, D, Tzardi, M, Mavroudis, D, Bairaktari, E, Arvanity, H, Stathopoulos, E, Georgoulias, V, Souglakos, J
Publicado em 2010

A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit

Por Brunetto, A T, Sarker, D, Papadatos-Pastos, D, Fehrmann, R, Kaye, S B, Johnston, S, Allen, M, De Bono, J S, Swanton, C
Publicado em 2010